Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review

Imagem de Miniatura
Arquivos
art_MAIA_Biomarkers_in_NonSchistosomiasisrelated_squamous_cell_carcinoma_of_the_2019.PDF (287.65 KB)
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
MAIA, Manuel Caitano
HANSEN, Aaron
SALAH, Samer
Citação
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, v.135, p.76-84, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Non-urothelial (NU) histologies represent less than 10% of bladder cancers, with squamous cell carcinoma (SCC) being the most common subtype (approximately 5%). Bladder SCCs are subdivided into Schistosoma-related or non-Schistosoma-related tumors, with the latter being the most frequent subtype in the western world. Typically, these patients have been excluded or under-represented in clinical trials and thus little is known about treatment efficacy in bladder SCC. To address this paucity of data, extrapolation from urothelial carcinoma (UC) trials can be performed but this approach has inherent limitations. In the era of precision medicine, efforts to characterize the genomic and molecular profiles of bladder tumors may yield evidence to support new targets for effective therapies. We reviewed the available data on biomarkers of bladder SCC and provide suggestions on how these may influence therapeutic testing and clinical trials in the future.
Palavras-chave
Biomarkers, Squamous, Bladder, Non-Bilharzial, Non-Schistosomiasis
URI
https://observatorio.fm.usp.br/handle/OPI/31872
Referências
  1. Abdollah F, 2012, BJU INT, V109, P564, DOI 10.1111/j.1464-410X.2011.10357.x
  2. Abdulamir AS, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-27
  3. Abol-Enein H, 2007, UROLOGY, V69, P93, DOI 10.1016/j.urology.2006.08.1107
  4. Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010
  5. Apolo AB, 2017, J CLIN ONCOL, V35, P2117, DOI 10.1200/JCO.2016.71.6795
  6. Aragon-Ching Jeanny B, 2018, J CLIN ONCOL S6S, V36
  7. Badr KM, 2004, HUM PATHOL, V35, P184, DOI 10.1016/j.humpath.2003.10.006
  8. Balar A, 2016, ANN ONCOL, V27, DOI [10.1093/annonc/mdw435.25.LBA32_PR-LBA32_PR, DOI 10.1093/ANNONC/MDW435.25.LBA32_PR-LBA32_PR]
  9. Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2
  10. BALAR AV, 2018, J CLIN ONCOL S, V36
  11. Baldia PH, 2016, ONCOTARGET, V7, P71429, DOI 10.18632/oncotarget.12198
  12. Bellmunt J, 2017, NEW ENGL J MED, V376, P1015, DOI 10.1056/NEJMoa1613683
  13. Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409
  14. Brahmer J, 2015, NEW ENGL J MED, DOI [10.1056/NEJMoa1504627.150531143008000-150531143008000, DOI 10.1056/NEJMOA1504627.150531143008000-150531143008000]
  15. Celis JE, 2000, ELECTROPHORESIS, V21, P2115
  16. Chalasani Venu, 2009, Can Urol Assoc J, V3, pS193
  17. Choi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129
  18. Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009
  19. Dahm P, 2003, EUR UROL, V44, P672, DOI 10.1016/S0302-2838(03)00416-0
  20. Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111
  21. Eissa S, 2005, CLIN BIOCHEM, V38, P142, DOI 10.1016/j.clinbiochem.2004.09.004
  22. El-Kenawy AE, 2006, INT J BIOL MARKER, V21, P170
  23. EL-Kenawy AE, 2003, INT J BIOL MARKER, V18, P284
  24. El-Rifai W, 2000, AM J PATHOL, V156, P871, DOI 10.1016/S0002-9440(10)64956-5
  25. Felix AS, 2008, CANCER CAUSE CONTROL, V19, P421, DOI 10.1007/s10552-007-9104-7
  26. Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252
  27. Fradet Y, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4521
  28. Gallo O, 2003, AM J PATHOL, V163, P723, DOI 10.1016/S0002-9440(10)63699-1
  29. Galsky MD, 2007, UROLOGY, V69, P255, DOI 10.1016/j.urology.2006.10.029
  30. GHONEIM MA, 1985, J UROLOGY, V134, P266, DOI 10.1016/S0022-5347(17)47119-9
  31. Ghoneim MA, 1997, J UROLOGY, V158, P393, DOI 10.1016/S0022-5347(01)64487-2
  32. Guo CC, 2009, HUM PATHOL, V40, P1448, DOI 10.1016/j.humpath.2009.03.005
  33. Haitel A, 2001, J UROLOGY, V165, P1481, DOI 10.1016/S0022-5347(05)66332-X
  34. Hammam O, 2015, ARAB J UROL, V13, P146, DOI 10.1016/j.aju.2015.01.004
  35. Hammam Olfat, 2014, J Egypt Soc Parasitol, V44, P733
  36. Higano CS, 2008, CANCER-AM CANCER SOC, V112, P2181, DOI 10.1002/cncr.23420
  37. Hirasawa E, 2002, J UROLOGY, V167, P2130, DOI 10.1016/S0022-5347(05)65104-X
  38. Hussain M, 2001, J CLIN ONCOL, V19, P2527, DOI 10.1200/JCO.2001.19.9.2527
  39. Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344
  40. James ND, 2012, NEW ENGL J MED, V366, P1477, DOI 10.1056/NEJMoa1106106
  41. Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
  42. Kassouf W, 2007, CANCER, V110, P764, DOI 10.1002/cncr.22853
  43. Kastritis E, 2006, ANTICANCER RES, V26, P3865
  44. Khaled HM, 2000, EUR J CANCER, V36, pS34, DOI 10.1016/S0959-8049(00)00079-4
  45. Kijima T, 2018, J CLIN ONCOL S6S, V36
  46. Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5
  47. Lagwinski N, 2007, AM J SURG PATHOL, V31, P1777, DOI 10.1097/PAS.0b013e31805c9cd9
  48. Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596
  49. LOCKE JR, 1985, J UROLOGY, V133, P1034, DOI 10.1016/S0022-5347(17)49366-9
  50. Makboul R, 2015, KOREAN J UROL, V56, P31, DOI 10.4111/kju.2015.56.1.31
  51. Manunta A, 2005, BJU INT, V95, P497, DOI 10.1111/j.1464-410X.2005.05327.x
  52. Martin JW, 2016, ARAB J UROL, V14, P183, DOI 10.1016/j.aju.2016.07.001
  53. McNiel EA, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2016.45
  54. Milowsky MI, 2014, EUR J CANCER, V50, P3145, DOI 10.1016/j.ejca.2014.10.013
  55. Milowsky MI, 2013, BJU INT, V112, P462, DOI 10.1111/j.1464-410X.2012.11720.x
  56. Molitor M, 2015, INT J CLIN EXP PATHO, V8, P8143
  57. Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665
  58. Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048
  59. Oing C, 2016, J UROLOGY, V195, P254, DOI 10.1016/j.juro.2015.06.115
  60. Omran OM, 2012, J ENVIRON PATHOL TOX, V31, P203, DOI 10.1615/JEnvironPatholToxicolOncol.v31.i3.20
  61. Ostergaard M, 1999, ELECTROPHORESIS, V20, P349
  62. Pal SK, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.4517
  63. Pannek J, 2002, UROLOGY, V59, P240, DOI 10.1016/S0090-4295(01)01495-9
  64. Porter MP, 2002, J UROLOGY, V168, P1960, DOI 10.1097/01.ju.0000034384.91899.67
  65. Powles T, 2018, LANCET, V391, P748, DOI 10.1016/S0140-6736(17)33297-X
  66. Powles T, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2411
  67. Powles T, 2017, J CLIN ONCOL, V35, P48, DOI 10.1200/JCO.2015.66.3468
  68. PREMPREE T, 1984, ACTA RADIOL ONCOL, V23, P37, DOI 10.3109/02841868409135983
  69. Pycha A, 1999, UROLOGY, V53, P1005, DOI 10.1016/S0090-4295(98)00626-8
  70. RAMCHURREN N, 1995, INT J CANCER, V62, P237, DOI 10.1002/ijc.2910620302
  71. Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4
  72. Shaker OG, 2013, BIOMED PHARMACOTHER, V67, P183, DOI 10.1016/j.biopha.2012.10.019
  73. Sharma P, 2017, LANCET ONCOL, V18, P312, DOI 10.1016/S1470-2045(17)30065-7
  74. Shokeir AA, 2004, BJU INT, V93, P216, DOI 10.1046/j.1464-410X.2004.04588.x
  75. Slim M, 2018, J CLIN ONCOL S6S, V36
  76. Soria JC, 2016, ANN ONCOL, V27, P2268, DOI 10.1093/annonc/mdw427
  77. Spradling K, 2016, UROL ONCOL, V34, pe411, DOI 10.1016/j.urolonc.2016.03.023
  78. STEIN JP, 1993, J UROLOGY, V149, P588, DOI 10.1016/S0022-5347(17)36156-6
  79. Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911
  80. SWANSON DA, 1990, J UROLOGY, V143, P37, DOI 10.1016/S0022-5347(17)39857-9
  81. Vaidyanathan Subramanian, 2002, BMC Urol, V2, P8, DOI 10.1186/1471-2490-2-8
  82. Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353
  83. Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965
  84. Welk B, 2013, SPINAL CORD, V51, P516, DOI 10.1038/sc.2013.33
  85. Westenend PJ, 2001, BJU INT, V88, P198, DOI 10.1046/j.1464-410x.2001.02230.x
  86. Wysolmerski JJ, 1998, ANNU REV PHYSIOL, V60, P431, DOI 10.1146/annurev.physiol.60.1.431
  87. Youssef R, 2011, BJU INT, V108, P31, DOI 10.1111/j.1464-410X.2010.09854.x
  88. Youssef RF, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.020
  89. Youssef RF, 2015, J UROLOGY, V193, P451, DOI 10.1016/j.juro.2014.08.109

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - ODS/03